Saida Yoshihisa, Sumiyama Yoshinobu, Nagao Jiro, Uramatsu Masashi
Third Department of Surgery, Toho University School of Medicine, Tokyo, Japan.
Dis Colon Rectum. 2003 Oct;46(10 Suppl):S44-9. doi: 10.1097/01.DCR.0000087483.63718.A2.
Expandable metallic stent endoprosthesis for preoperative "bridge to surgery" treatment of obstructive colorectal cancer has been broadly, clinically used with good short-term results. Stent insertion for malignant tumor, however, is controversial because of the increased risk of metastasis, invasion, and advancement of the cancer. We, first in the world, evaluated the long-term prognosis of expandable metallic stent insertion compared with emergency surgery without expandable metallic stent.
Forty emergency operations (1986-1996) and 44 expandable metallic stent insertions (1993-2001) were retrospectively compared by history, duration, morbidity, and cumulative survival rate.
There was no significant difference in age or lesion between the two groups. Postoperative complications were significantly less frequent in the expandable metallic stent group: wound infection was 14 vs. 2 percent; leakage following to anastomosis was 11 vs. 3 percent. Long-term prognosis did not significantly differ: three-year overall survival rate was 50 vs. 48 percent; five-year survival rate was 44 vs. 40 percent in the emergency operation and expandable metallic stent groups, respectively.
Because preoperative expandable metallic stent insertion for obstructive colorectal cancer had good postoperative results and no disadvantages in long-term prognosis, this procedure should be used in preoperative treatments of obstructive colorectal cancer.
可扩张金属支架内假体用于术前“手术桥梁”治疗梗阻性结直肠癌已在临床上广泛应用,短期效果良好。然而,由于恶性肿瘤插入支架会增加转移、侵袭和癌症进展的风险,因此存在争议。我们在世界上首次评估了与未插入可扩张金属支架的急诊手术相比,插入可扩张金属支架的长期预后。
回顾性比较了40例急诊手术(1986 - 1996年)和44例可扩张金属支架植入术(1993 - 2001年)的病史、持续时间、发病率和累积生存率。
两组在年龄或病变方面无显著差异。可扩张金属支架组术后并发症明显较少:伤口感染分别为14%和2%;吻合口漏分别为11%和3%。长期预后无显著差异:急诊手术组和可扩张金属支架组的三年总生存率分别为50%和48%;五年生存率分别为44%和40%。
由于术前插入可扩张金属支架治疗梗阻性结直肠癌术后效果良好,且长期预后无不良影响,因此该方法应用于梗阻性结直肠癌的术前治疗。